ICAM1 and acute kidney injury: Cisplatin-induced AKI is associated with the release of many soluble mediators and activation of adhesion molecules from activated or injured kidney cells (such as ICAM-1, TGF-β, TNF-α, IL-1β, and RANTES), which further attract and activate leukocytes to sites of injury [27].